Investment Summary |
|
|---|---|
| Date | 2010-11-10 |
| Target | RDA Microelectronics |
| Sector | Semiconductors |
| Sellers(s) | Warburg Pincus |
| Deal Type | IPO |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1966 |
| PE ASSETS | 83.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 54 of 265 |
| Sector: Semiconductors M&A | 2 of 2 |
| Type: IPO M&A Deals | 14 of 65 |
| Country: China M&A | 5 of 28 |
| Year: 2010 M&A | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-04 |
Accriva Diagnostics
San Diego, California, United States Accriva Diagnostics is a leader in hemostasis management and POC testing. Accriva develops, manufactures, and markets: Hemochron® and ProTime® POC coagulation systems; IRMA TruPoint® Blood Gas and Electrolyte systems; Avoximeter® CO-Oximetry systems; and Tenderfoot®, Tenderlett® and Surgicutt® skin incision products. |
Buy | $55M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-22 |
Evidon
New York, New York, United States Evidon, Inc. is a technology company focused on simplifying the complex world of Digital Governance. Fulfilling this promise requires organisations to have a comprehensive approach to govern data collection across their websites, applications and ads while complying with global regulations. Evidon, Inc. was established in 2009 and is based in New York, New York. |
Buy | - |
